Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Prestige Consumer Healthcare Inc is a medical distribution business based in the US. Prestige Consumer Healthcare shares (PBH) are listed on the NYSE and all prices are listed in US Dollars. Prestige Consumer Healthcare employs 520 staff and has a trailing 12-month revenue of around USD$959.6 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Mobile users
Latest market close | USD$36.73 |
---|---|
52-week range | USD$27.4 - USD$45.81 |
50-day moving average | USD$35.2863 |
200-day moving average | USD$37.1804 |
Wall St. target price | USD$42.75 |
PE ratio | 11.7414 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$3.21 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $36.73 from 2020-12-11
1 week (2021-01-09) | N/A |
---|---|
1 month (2020-12-16) | 2.14% |
3 months (2020-10-16) | N/A |
6 months (2020-07-16) | N/A |
1 year (2020-01-16) | N/A |
---|---|
2 years (2019-01-16) | N/A |
3 years (2018-01-16) | N/A |
5 years (2016-01-16) | N/A |
Valuing Prestige Consumer Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Prestige Consumer Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Prestige Consumer Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Prestige Consumer Healthcare shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Prestige Consumer Healthcare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.8625. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Prestige Consumer Healthcare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Prestige Consumer Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$342.3 million.
The EBITDA is a measure of a Prestige Consumer Healthcare's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$959.6 million |
---|---|
Operating margin TTM | 32.57% |
Gross profit TTM | USD$565.7 million |
Return on assets TTM | 5.66% |
Return on equity TTM | 13.67% |
Profit margin | 17.03% |
Book value | $25.482 |
Market capitalisation | USD$1.9 billion |
TTM: trailing 12 months
There are currently 3.6 million Prestige Consumer Healthcare shares held short by investors – that's known as Prestige Consumer Healthcare's "short interest". This figure is 12.7% down from 4.1 million last month.
There are a few different ways that this level of interest in shorting Prestige Consumer Healthcare shares can be evaluated.
Prestige Consumer Healthcare's "short interest ratio" (SIR) is the quantity of Prestige Consumer Healthcare shares currently shorted divided by the average quantity of Prestige Consumer Healthcare shares traded daily (recently around 412005.29953917). Prestige Consumer Healthcare's SIR currently stands at 8.68. In other words for every 100,000 Prestige Consumer Healthcare shares traded daily on the market, roughly 8680 shares are currently held short.
However Prestige Consumer Healthcare's short interest can also be evaluated against the total number of Prestige Consumer Healthcare shares, or, against the total number of tradable Prestige Consumer Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Prestige Consumer Healthcare's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Prestige Consumer Healthcare shares in existence, roughly 70 shares are currently held short) or 0.094% of the tradable shares (for every 100,000 tradable Prestige Consumer Healthcare shares, roughly 94 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Prestige Consumer Healthcare.
Find out more about how you can short Prestige Consumer Healthcare stock.
We're not expecting Prestige Consumer Healthcare to pay a dividend over the next 12 months.
Over the last 12 months, Prestige Consumer Healthcare's shares have ranged in value from as little as $27.4 up to $45.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Prestige Consumer Healthcare's is 0.7554. This would suggest that Prestige Consumer Healthcare's shares are less volatile than average (for this exchange).
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.